-
Posted by
Two Blokes Jul 2 -
Filed in
Stock
-
3 views
IDEX delivers steady cash flow and high margins from niche industrial markets, supported by a diversified portfolio and mission-critical products. Financial health is robust, with strong free cash flow, moderate leverage, and consistent shareholder returns via dividends and buybacks. The growth outlook is modest (1–3% organic sales, $8.10–8.45 EPS), but the valuation is fair given stability, efficiency, and resilience to market shocks.
